Information;Judgment — ECLI:EU:T:2020:405
Date: 2020-09-09
Language of the case: English
Court formation: Sixth Chamber
Subject matter: Trade marks;Intellectual, industrial and commercial property
Procedure: Action for annulment - unfounded
Origin: United Kingdom

Judgment of the General Court of 9 September 2020 – Glaxo Group Ltd v EUIPO (Shade of the colour purple) (Case T-187/19) 1 (EU trade mark – Application for an EU trade mark consisting of a shade of the colour purple – Absolute ground for refusal – Lack of distinctive character – Article 7(1)(b) of Regulation (EU) 2017/1001 – Lack of distinctive character acquired through use – Article 7(3) of Regulation 2017/1001) Language of the case: English Parties Applicant: Glaxo Group Ltd (Brentford, United Kingdom) (represented by: S. Malynicz, QC, S. Baran, Barrister, and R. Jacob, Solicitor) Defendant: European Union Intellectual Property Office (represented by: S. Hanne and H. O’Neill, acting as Agents) Re: Action brought against the decision of the First Board of Appeal of EUIPO of 15 January 2019 (Case R 1870/2017-1), concerning an application for registration of a sign consisting of a shade of the colour purple as an EU trade mark: Operative part of the judgment The Court: 1. Dismisses the action; 2. Orders Glaxo Group Ltd to pay the costs. ____________ 1 OJ C 172, 20.5.2019.